Cargando…
Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury
Although coronary thrombus overlying a disrupted atherosclerotic plaque has long been considered the hallmark and the primary therapeutic target for acute myocardial infarction (MI), multiple other mechanisms are now known to cause or contribute to MI. It is further recognized that an MI is just one...
Autores principales: | DeFilippis, Andrew P., Chapman, Andrew R., Mills, Nicholas L., de Lemos, James A., Arbab-Zadeh, Armin, Newby, L. Kristin, Morrow, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855329/ https://www.ncbi.nlm.nih.gov/pubmed/31416350 http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040631 |
Ejemplares similares
-
2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction
por: Chang, Kiyuk, et al.
Publicado: (2021) -
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013) -
Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease
por: Hernandez, Melissa J., et al.
Publicado: (2017) -
A Proposal for Modest Revision of the Definition of Type 1 and Type 2 Myocardial Infarction
por: de Lemos, James A., et al.
Publicado: (2019) -
Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation
por: Trankle, Cory, et al.
Publicado: (2016)